| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_011687f00f36eb0010ac0142d913f1d1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2529-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0656
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-861
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-867
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1875
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 |
| filingDate |
2006-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cfaaa656a98275239535785a32cff73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c39c5da9969fbebcc7595dfbbee40cb3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93f7a2b23bd3c249e2336c7a3b667bea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19c1c970c45bbf06fb22e652252a9ea2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c51c3086ba1c9476d56654830d3bead8 |
| publicationDate |
2013-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20130101595-A |
| titleOfInvention |
Neuroprotective compounds |
| abstract |
The present application provides a) a recombinant viral vector or plasmid vector comprising a DNA sequence encoding a transforming growth factor superfamily or neurotrophic factor protein operably linked to a promoter. Manufacturing; b) transfecting said recombinant vector into a population of cultured cells to form a population of cultured cells; And c) implanting the transfected cell population in the peripheral region of the damaged nerve, thereby expressing the DNA sequence in the peripheral region of the damaged nerve, thereby preventing nerve degeneration. |
| priorityDate |
2005-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |